Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,481 | 55,629 | 68,740 | 86,327 | 94,386 |
| Receivables | 23,690 | 23,594 | 26,360 | 34,627 | 29,843 |
| Inventories | 18,787 | 23,809 | 24,428 | 39,765 | 36,010 |
| Other current assets | 0 | 5,126 | 36,305 | 0 | 0 |
| TOTAL | $103,358 | $113,652 | $163,309 | $169,547 | $168,528 |
| Non-Current Assets | |||||
| PPE Net | 40,324 | 38,994 | 37,445 | 48,279 | 47,602 |
| Intangibles | 9,704 | 9,615 | 10,147 | 81,938 | 90,163 |
| Other Non-Current Assets | 36,884 | 40,479 | 59,731 | 49,364 | 41,242 |
| TOTAL | $86,912 | $89,088 | $107,323 | $179,581 | $179,007 |
| Total Assets | $190,270 | $202,740 | $270,632 | $349,128 | $347,535 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,041 | 5,617 | 6,194 | 9,074 | 7,633 |
| Accrued Expenses | 15,867 | 13,567 | 14,066 | 18,840 | 17,847 |
| Other current liabilities | N/A | 4,122 | 10,799 | N/A | 4,315 |
| TOTAL | $21,908 | $23,306 | $31,059 | $27,914 | $29,795 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 24,897 | 25,445 | 27,308 | 29,215 | 20,498 |
| TOTAL | $24,897 | $25,445 | $27,308 | $35,651 | $30,655 |
| Total Liabilities | $46,805 | $48,751 | $58,367 | $63,565 | $60,450 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,401 | 14,176 | 14,850 | 14,633 | 14,467 |
| Common Shares | 139 | 144 | 147 | 146 | 144 |
| Retained earnings | 60,787 | 71,667 | 128,052 | 210,719 | 225,578 |
| Other shareholders' equity | -4,959 | -6,783 | -5,943 | -6,443 | -5,718 |
| TOTAL | $143,465 | $153,989 | $212,265 | $285,563 | $287,085 |
| Total Liabilities And Equity | $190,270 | $202,740 | $270,632 | $349,128 | $347,535 |